 |
|
 |
 |

Home > Company Index > Drugs > Drug Delivery > IOMED, Inc.
 |
IOMED, Inc. |
 |
 |
 |
PROFILE |
 |
IOMED hopes to make fear of needles a thing of the past. The company's iontophoretic drug delivery system, the Phoresor System, delivers water-soluble ionic drugs through a patient's skin via low levels of electricity. The advantages of this technology cited by IOMED include less invasive drug-delivery, less frequent and more programmable dosing, and rapid onset of relief. The FDA has approved the delivery system for a local dermal anesthetic, which is marketed to pediatricians under the Numby Stuff brand. The company thinks its products can be leveraged into the ophthalmic, local inflammation, and pain management markets as well. Elan Corporation owns about 30% of IOMED.
COMPETITION |
 |
ALZA Corporation (dossier)
Becton, Dickinson and Company (BDX)
Empi, Inc. (dossier)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: June
2000 Sales (mil.): 10.80
1-Yr. Sales Growth: 2.9%
Employees: 70
Revenue per employee: $154,285.71
KEY PEOPLE |
 |
James R. Weersing
CEO
Robert J. Lollini
CFO
CONTACT INFO |
 |
3385 W. 1820 South
Salt Lake City, UT 84104
US
Phone: 801-975-1191
Fax: 801-972-9072
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |